Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 125 of 1674 entries
View as:

Peer-Led Healthy Lifestyle Program in Supportive Housing

Phase: N/A Priority: Normal
NCT ID: NCT02175641 Org: User:
Start: 07/31/15 End: 07/31/19 Due: 07/31/20

Ultrasound and Photoacoustic Imaging for Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03318107 Org: User:
Start: 02/15/18 End: 08/09/19 Due: 08/09/20

Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT01065129 Org: User:
Start: 09/02/10 End: 10/18/16 Due: 10/18/17

Increasing Optimal Use of HPV Vaccination in Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT04180462 Org: User:
Start: 01/07/20 End: 04/29/24 Due: 04/29/25

Endometriosis Pain

Phase: N/A Priority: Normal
NCT ID: NCT06101303 Org: User:
Start: 09/29/23 End: 09/01/29 Due: 09/01/30

Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT06538181 Org: User:
Start: 02/13/25 End: 02/28/29 Due: 02/28/30

Impact of a Neonatal-Bereavement-Support DVD on Grief

Phase: N/A Priority: Normal
NCT ID: NCT01926080 Org: User:
Start: 01/31/08 End: 08/09/17 Due: 08/09/18

The Role of Cholinergic Signaling for Mediating the Effects of GIP and/or Xenin-25 on Insulin Secretion

Phase: N/A Priority: Normal
NCT ID: NCT01951729 Org: User:
Start: 03/13/13 End: 05/31/15 Due: 05/31/16

Bilateral vs Unilateral CTR

Phase: N/A Priority: Normal
NCT ID: NCT01961011 Org: User:
Start: 06/30/12 End: 03/31/14 Due: 03/31/15

Choline to Prevent SAM in Children With MAM

Phase: N/A Priority: Normal
NCT ID: NCT06214897 Org: User:
Start: 03/18/24 End: 02/28/26 Due: 02/28/27

Emergency Department (ED) Flow-directed Fluid Optimization Resuscitation Trial (EFFORT)

Phase: N/A Priority: Normal
NCT ID: NCT01128413 Org: User:
Start: 07/31/10 End: 11/30/13 Due: 11/30/14

BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT02763384 Org: User:
Start: 12/02/16 End: 05/22/22 Due: 05/22/23

Prevention of Noise-induced Hearing Loss

Phase: N/A Priority: Normal
NCT ID: NCT02049073 Org: User:
Start: 10/31/17 End: 11/01/17 Due: 11/01/18

Promoting Physical Activity in Rural Communities

Phase: N/A Priority: Normal
NCT ID: NCT03683173 Org: User:
Start: 12/17/18 End: 12/24/22 Due: 12/24/23

Total vs. Reverse Shoulder Replacement: Pain Relief Two Years After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01884077 Org: User:
Start: 11/30/12 End: 06/30/16 Due: 06/30/17

HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy

Phase: N/A Priority: Normal
NCT ID: NCT06844669 Org: User:
Start: 04/16/25 End: 01/31/26 Due: 01/31/27

Selinexor and Lenalidomide for Consolidation and Maintenance Treatment in Multiple Myeloma Post-transplant

Phase: N/A Priority: Normal
NCT ID: NCT05820763 Org: User:
Start: 01/05/24 End: 01/31/27 Due: 01/31/28

The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00316472 Org: User:
Start: 04/30/06 End: 12/31/07 Due: 12/31/08

Chromosome 9 P Minus Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT04586400 Org: User:
Start: 06/27/17 End: 06/30/26 Due: 06/30/27

Telephone Coaches to Improve Control of Asthma in Children ( PARTNER) Study)

Phase: N/A Priority: Normal
NCT ID: NCT00860834 Org: User:
Start: 08/31/08 End: 05/03/14 Due: 05/03/15

Diabetic Shoulder Mobility

Phase: N/A Priority: Normal
NCT ID: NCT02162212 Org: User:
Start: 09/30/14 End: 10/12/16 Due: 10/12/17

Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00921310 Org: User:
Start: 09/30/09 End: 04/30/16 Due: 04/30/17

Escalation of Daratumumab Frequency Following Biochemical Progression in Relapsed/Refractory Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT04150692 Org: User:
Start: 01/08/21 End: 03/31/26 Due: 03/31/27

Low Dialysate Temperature During SLED

Phase: N/A Priority: Normal
NCT ID: NCT03397992 Org: User:
Start: 01/16/17 End: 04/22/17 Due: 04/22/18

Mature Dendritic Cell Vaccination Against Unique Immunogenic Peptides in Patients With Non Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT02419170 Org: User:
Start: 07/31/16 End: 10/31/23 Due: 10/31/24